Han Suk Ryu

4.6k total citations · 1 hit paper
141 papers, 3.0k citations indexed

About

Han Suk Ryu is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Han Suk Ryu has authored 141 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Oncology, 46 papers in Molecular Biology and 41 papers in Cancer Research. Recurrent topics in Han Suk Ryu's work include Breast Cancer Treatment Studies (21 papers), Cancer Cells and Metastasis (18 papers) and HER2/EGFR in Cancer Research (16 papers). Han Suk Ryu is often cited by papers focused on Breast Cancer Treatment Studies (21 papers), Cancer Cells and Metastasis (18 papers) and HER2/EGFR in Cancer Research (16 papers). Han Suk Ryu collaborates with scholars based in South Korea, United States and Cyprus. Han Suk Ryu's co-authors include Wonshik Han, Ilias P. Nikas, Han‐Byoel Lee, Woo Kyung Moon, Woong‐Yang Park, Hae‐Ock Lee, Zhengyan Kan, Yeon Hee Park, Hye Hyeon Eum and Kyung Min Lee and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Han Suk Ryu

140 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Single-cell RNA-seq enables comprehensive tumour and immune cell profiling in primary breast cancer

2017 691 citations Han‐Byoel Lee, Han Suk Ryu et al. profile →

Peers

Countries citing papers authored by Han Suk Ryu

Since Specialization

Citations

This map shows the geographic impact of Han Suk Ryu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Han Suk Ryu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Han Suk Ryu more than expected).

Fields of papers citing papers by Han Suk Ryu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Han Suk Ryu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Han Suk Ryu. The network helps show where Han Suk Ryu may publish in the future.

Co-authorship network of co-authors of Han Suk Ryu

This figure shows the co-authorship network connecting the top 25 collaborators of Han Suk Ryu. A scholar is included among the top collaborators of Han Suk Ryu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Han Suk Ryu. Han Suk Ryu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	MSN/STAT3 drives cancer stemness and chemoresistance via IL-6/LPAR1 ligand receptor complex in triple-negative breast cancer 2025 ·Breast Cancer Research ·(unknown), Soo Young Park, Jae Seok Lee, (unknown), Ha Yeon Kim, Min Ji Song, Seock‐Ah Im, Kyung-Hun Lee, (unknown), Ilias P. Nikas, (unknown), (unknown), Hyebin Lee, Han Suk Ryu	1
2	DNA damage and Nuclear Anaplasia Induced by Trastuzumab Deruxtecan in Cancer Cells with Variable HER2 Expression and Homologous Recombination Deficiency Status 2025 ·Cancer Research and Treatment ·So Hyeon Kim, Young Joo Park, Ahrum Min, (unknown), Yu‐Jin Kim, (unknown), Jiwon Koh, Seongyeong Kim, Dae‐Won Lee, Han Suk Ryu, Jin‐Soo Kim, Kyung-Hun Lee, Seock Ah Im	1
3	Diagnostic Challenges during Inflammation and Cancer: Current Biomarkers and Future Perspectives in Navigating through the Minefield of Reactive versus Dysplastic and Cancerous Lesions in the Digestive System 2024 ·International Journal of Molecular Sciences ·Ioannis S. Pateras, Ana Igea, Ilias P. Nikas, (unknown), Nektarios Koufopoulos, (unknown), (unknown), Han Suk Ryu, Antonios Chatzigeorgiou, Teresa Frisan, Christos Kittas, Ioannis Panayiotides	4
4	A phase II study of tepotinib in patients with advanced solid cancers harboring MET exon 14 skipping mutations or amplification (KCSG AL19-17) 2024 ·ESMO Open ·Eun Joo Kang, Yaewon Yang, Sang-Ho Lee, Yu Jung Kim, Seungtaek Lim, (unknown), Yoon Ji Choi, Yong Jae Lee, Tae Min Kim, (unknown), Hee Kyung Ahn, (unknown), (unknown), So Yeon Oh, Woo Kyun Bae, Han Suk Ryu, Kang Hyun Park, KK Lee	2
5	The Diagnostic Accuracy of Claudin-4 Immunochemistry in Differentiating Metastatic Carcinomas From Mesothelial Processes in Serous Effusion Cytology: A Systematic Review and Meta-analysis 2024 ·Archives of Pathology & Laboratory Medicine ·(unknown), Johannes A. Vey, (unknown), Angela Ishak, (unknown), Han Suk Ryu, Ilias P. Nikas	2
6	Immune marker expression and prognosis of early breast cancer expressing HER3 2024 ·European Journal of Cancer ·(unknown), Han Suk Ryu, Ilias P. Nikas, Jiwon Koh, Tae-Yong Kim, Hong Kyu Kim, Han‐Byoel Lee, Hyeong‐Gon Moon, Wonshik Han, Kyung-Hun Lee, Seock‐Ah Im	4
7	Multi-targeted therapy resistance via drug-induced secretome fucosylation 2023 ·eLife ·(unknown), Junghwa Cha, (unknown), (unknown), Pavel Sinitcyn, (unknown), (unknown), (unknown), Dongwook Kim, Soyeon Kim, Minjeong Kang, (unknown), Geonho Park, Hye-Jin Sung, Han Suk Ryu, Sukki Cho, Tae Min Kim, Pilnam Kim, Je‐Yoel Cho, Yoosik Kim	8
8	Prognostic Role of Androgen Receptor Expression in Surgically Resected Early Breast Cancer Patients 2020 ·Journal of Breast Cancer ·Yaewon Yang, Ahrum Min, Kyung-Hun Lee, Han Suk Ryu, Tae‐Yong Kim, (unknown), Koung Jin Suh, Dae‐Won Lee, Han‐Byoel Lee, Hyeong‐Gon Moon, Wonshik Han, In Ae Park, Dong‐Young Noh, Seock‐Ah Im	9
9	Tryptophanyl-tRNA Synthetase Sensitizes Hormone Receptor-Positive Breast Cancer to Docetaxel-Based Chemotherapy 2020 ·Journal of Breast Cancer ·(unknown), Eun Hye Hwang, (unknown), (unknown), Hyebin Lee, Hyeon Jeong Oh, Kwangsoo Kim, Jiwon Koh, Han Suk Ryu	6
10	Prior acquired resistance to paclitaxel relays diverse EGFR-targeted therapy persistence mechanisms 2020 ·Science Advances ·(unknown), (unknown), Ji‐Young Hong, Donghwa Kim, Seung Jung Yu, Min-Seok Lee, (unknown), (unknown), (unknown), Jinju Han, Sang Kook Lee, Sung Gap Im, Han Suk Ryu, Yoosik Kim	32
11	Antitumor effect of a WEE1 inhibitor and potentiation of olaparib sensitivity by DNA damage response modulation in triple-negative breast cancer 2020 ·Scientific Reports ·(unknown), Ahrum Min, Seongyeong Kim, Hyemin Jang, So Hyeon Kim, Hee Jun Kim, Han Suk Ryu, Ja‐Lok Ku, Kyung-Hun Lee, Seock‐Ah Im	56
12	Molecular Profiling of Malignant Pleural Effusions with Next Generation Sequencing (NGS): Evidence that Supports Its Role in Cancer Management 2020 ·Journal of Personalized Medicine ·(unknown), Stepan M. Esagian, Han Suk Ryu, Ilias P. Nikas	17
13	Expression of Indoleamine 2,3-Dioxygenase and Infiltration of FOXP3+ Regulatory T Cells Are Associated with Aggressive Features of Papillary Thyroid Microcarcinoma 2014 ·Thyroid ·Han Suk Ryu, Young Soo Park, Hyo Jin Park, Yul Ri Chung, Cha Kyong Yom, Soon‐Hyun Ahn, Young Joo Park, Seong Hoe Park, So Yeon Park, (unknown), (unknown)	24
14	Liquid-Based Fine Needle Aspiration Biopsy of Papillary Thyroid Carcinoma: Logistic Regression Analysis with Conventional and New Cytomorphologic Features 2013 ·Acta Cytologica ·Jae Seok Lee, Heeseung Choi, In Ae Park, Han Suk Ryu	14
15	Overexpression of epithelial-mesenchymal transition–related markers according to cell dedifferentiation: clinical implications as an independent predictor of poor prognosis in cholangiocarcinoma 2012 ·Human Pathology ·Han Suk Ryu, Jin-Haeng Chung, Kyoung Bun Lee, Eun Ji Shin, Jing Jin, Gheeyoung Choe, Haeryoung Kim, Xianhua Xu, Hee Eun Lee, Dae-Ghon Kim, Hyebin Lee, Ja–June Jang	24
16	Euthyroid Status After Total Thyroidectomy Due to Functioning Lung Metastases from a Clear Cell Variant of Papillary Thyroid Carcinoma 2012 ·Thyroid ·Ji In Lee, Yun Jae Chung, Sung Jun Park, Han Suk Ryu, Bo Youn Cho	5
17	Ectopic Intrapulmonary Thyroid Tissue Mimicking Metastatic Tissue 2012 ·Thyroid ·Han Suk Ryu, Yun Jae Chung, Semin Chong, Ji In Lee	11
18	Promoter CpG island hypermethylation during breast cancer progression 2010 ·Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin ·So Yeon Park, Hyeong Ju Kwon, Hee Eun Lee, Han Suk Ryu, Sung‐Won Kim, Jee Hyun Kim, In Ah Kim, Namgee Jung, Nam-Yun Cho, Gyeong Hoon Kang	126
19	Inhibitory Effect of Turnip Extract Fractions on Hepatic Fibrogenesis 2006 ·Laboratory Animal Research ·(unknown), Soo Young Park, Kyoung Bun Lee, (unknown), Han Suk Ryu, Min Su Kim, (unknown), Young Jin Kim, (unknown)	2
20	Cytomorphologic Comparison of Hodgkin Lymphoma and Anaplastic Large cell Lymphoma in Fine Needle Aspiration Cytology 2006 ·Jae‐Soo Koh, Sunhoo Park, Minsuk Kim, (unknown), (unknown), Han Suk Ryu, Jungsoon Kim, (unknown), (unknown), Seung‐Sook Lee	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact